| ADIL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ADIL shares outstanding history going back to 7/27/2018:
Also see: ADIL Market Cap History ADIL YTD Return |
ADIL Shares Outstanding History — ADial Pharmaceuticals Share Count Over Time
As of 5/6/2026 ADial Pharmaceuticals has 2.14 million ADIL shares outstanding. Investors often track the ADIL shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ADIL share count trends over time, with 33 historical shares outstanding datapoints presented, dating back to 7/27/2018.
| ADIL Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADIL Historical Shares Outstanding: +98.05% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADIL Stock Price Chart |
| About ADial Pharmaceuticals Inc |
| Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the development of treatments for addictions and related disorders. Co.'s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients. AD04 is investigated in the Co.'s ONWARD pivotal Phase III clinical trial for the treatment of AUD in subjects with certain target genotypes (estimated to be approximately one-third of the AUD population) identified using the Co.'s companion diagnostic genetic test. We show 33 historical shares outstanding datapoints in our coverage of ADIL's shares outstanding history. Understanding the changing numbers of ADIL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ADIL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ADIL by allowing them to research ADIL shares outstanding history as well as any other stock in our coverage universe. |
| ADIL Current Stock Quote |
Quotes delayed 20 minutes  Free ADIL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ADIL Share Performance |
| Shares Outstanding Peers |
| ADial Pharmaceuticals (ADIL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ADMA Shares Outstanding History ADMP Shares Outstanding History ADMS Shares Outstanding History ADPT Shares Outstanding History ADRO Shares Outstanding History ADTX Shares Outstanding History ADUS Shares Outstanding History ADVM Shares Outstanding History ADXS Shares Outstanding History ADYX Shares Outstanding History More Healthcare companies » |
ADIL Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
